Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-08-13
1993-01-05
Rizzo, Nicholas S.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142362, 5142365, 514340, 514369, 514371, 544124, 544132, 544141, 544152, 544157, 544158, 544159, 544162, 544170, 544171, 546276, 546283, 548182, 548183, 548185, 548187, 548189, 548190, 548191, 548193, 548194, 548195, 548196, 548202, 548204, 5482634, 5482642, 5482644, 5482666, 5482662, 5482664, 5482668, A61K 3141, A01N 4364, C07D41300, C07D41314, C07D40310, C07D40314, C07D24908
Patent
active
051770954
ABSTRACT:
Substituted triazoles attached through a methylene bridge to novel substituted phenyl derivatives of the Formula I, are useful as angiotensin II antagonists. ##STR1##
Ashton Wallace
Dhanoa Daljit S.
Fitch Kenneth J.
Greenlee William J.
Hangauer David
Camara Valerie J.
DiPrima Joseph F.
Gupta Y. N.
Merck & Co. , Inc.
Nicholson William H.
LandOfFree
Triazole angiotensin II antagonists incorporating a substituted does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazole angiotensin II antagonists incorporating a substituted , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazole angiotensin II antagonists incorporating a substituted will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2390786